ERBB2 and breast carcinoma: Taking this into consideration, together with the fact that iTILs-TIM-3+ seem to be a favorable prognostic factor in breast cancer, a prognosis analysis, within the different mammary carcinoma subtypes (LA/LB, HER-2+, and triple-negative), was performed in this study.